5% Off
5% Off
marketed by CIPLA GENERIC
• 10CAP
Out of stock
₹94.05
M.R.P.: ₹99
5% Off
Inclusive of all taxes
Lariago tablet is a proton pump inhibitor used to treat erosive esophagitis, gastric ulcer, gastroesophageal reflux disease, heartburn, helicobacter pylori gastrointestinal tract infection, ulcer of the duodenum, and zollinger-ellison syndrome. This medication may cause side effects such as abdominal pain, constipation, diarrhoea, nausea, headache, cutaneous lupus erythematosus, hypomagnesemia,
Clostridium difficile bacterial infection caused diarrhoea. Vitamin b12 insufficiency. Low levels of magnesium in the blood. Severe liver disease. Interstitial nephritis. Osteoporosis Cyp2c19 poor metabolizer.
Babies: Not applicable.
Lactating mother: It is safe to use during breastfeeding if prescribed by the doctor.
Limited human data shows that the drug does not cause any significant risk to the baby.
Consult your doctor before using this medication.
Pregnancy: It is safe to use during pregnancy if prescribed by your doctor.
Animal studies have shown low or no adverse effects to the developing baby; there are limited human studies.
Consult your doctor before using this medication.
Alcohol: Avoid alcohol while taking this medicine.
Driving: It may affect your ability to drive by impairing vision or make you feel sleepy and dizzy.
Do not drive if these symptoms occur.
Kidney: It is safe to use in patients with kidney disease if prescribed by the doctor.
No dose adjustment is recommended.
Consult your doctor before using this medication.
Liver: It should be used with caution in patients with severe liver disease.
You may need a dose adjustment.
Consult your doctor before using this medication..
Abdominal pain Constipation Diarrhoea Nausea Headache Cutaneous lupus erythematosus Hypomagnesemia Clostridium difficile diarrhoea Fundic gland polyposis of the stomach Pancreatitis Erythema multiforme Stevens-Johnson syndrome Toxic epidermal necrolysis Fracture of bone Rhabdomyolysis Tubulointerstitial nephritis.
Lariago tablet is a proton pump inhibitor. It works by decreasing gastric acid production in the stomach and improves symptoms..
If you miss a dose, take it as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• Lariago tablet is prescribed to treat erosive esophagitis, gastric ulcer, gastroesophageal reflux disease, heartburn, helicobacter pylori gastrointestinal tract infection, ulcer of the duodenum, and zollinger-ellison syndrome.
• Inform your doctor if diarrhoea does not improve.
Consult your doctor before taking antidiarrheal agents.
• This drug may cause side effects such as diarrhoea, abdominal pain, nausea, and constipation.
Inform your doctor if these effects bother or worsen your condition.
• Avoid the use of st.
John's wort while taking this drug.
• Take this medication before food at least for 30 minutes.
• Avoid alcohol consumption and smoking.
• Take a magnesium-rich diet as the drug may cause hypomagnesemia.
• Inform your doctor if you find decreased urination, lower back pain, oedema or fever..
• Lariago + Rilpivirine: Concurrent use of these medications may result in reduced rilpivirine plasma concentrations and risk of diminished therapeutic effect of rilpivirine. • Lariago + Acalabrutinib: Concurrent use of these medications may result in reduced acalabrutinib exposure. • Lariago + Bosutinib: Concurrent use of these medications may result in decreased bosutinib exposure. • Lariago + Amphetamines: Concurrent use of these medications may result in increased exposure to amphetamine. • Lariago + Capecitabine: Concurrent use of these medications may result in a reduction in capecitabine bioavailability. • Lariago + Clopidogrel: Concurrent use of these medications may result in reduced antiplatelet activity. • Lariago + Dacomitinib: Concurrent use of these medications may result in reduced dacomitinib exposure. • Lariago + Clarithromycin: Concurrent use of these medications may result in glossitis, stomatitis, or black tongue. • Lariago + Selperactinib: Concurrent use of these medications may result in reduced selpercatinib exposure and anti-tumour activity. • Lariago + Voriconazole: Concurrent use of these medications may result in increased plasma concentrations of lariago. • Lariago + Iron: Concurrent use of these medications may result in reduced iron bioavailability. • Lariago + Acenocoumarol: Concurrent use of these medications may result in elevated international normalized ratio serum values and potentiation of anticoagulation effects. • Lariago + Digoxin: Concurrent use of these medications may result in an increased risk of digoxin toxicity • Lariago + Ampicillin: Concurrent use of these medications may result in loss of ampicillin efficacy. • Lariago + Levothyroxine: Concurrent use of these medications may result in decreased levothyroxine effectiveness..
100% Authentic
Easy Return